Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients

NCT00224003 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Watson Pharmaceuticals